Jan 7, 2026 06:40AM Bright Minds Biosciences Inc. (DRUG) PT Raised to $147 at BTIG

Dec 31, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Bright Minds Biosciences Inc. (DRUG)

Dec 19, 2025 09:06AM TD Cowen on Biotechnology: '10+ Potential "Thome Run" Catalysts To Watch In 2026'

Dec 1, 2025 07:04AM Bright Minds Biosciences' (DRUG) BMB-101 Has $238 Sales Potential - Cantor Fitzgerald

Nov 11, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Bright Minds Biosciences Inc. (DRUG)

Nov 6, 2025 06:31AM Bright Minds Biosciences launches Prader-Willi Syndrome program

Sep 15, 2025 07:35AM H.C. Wainwright Reiterates Buy Rating on Bright Minds Biosciences Inc. (DRUG)

Sep 8, 2025 05:17AM BTIG Starts Bright Minds Biosciences Inc. (DRUG) at Buy

Aug 20, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Bright Minds Biosciences Inc. (DRUG)

May 13, 2025 08:31AM Bright Minds Biosciences (DRUG) Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101

May 13, 2025 04:52AM TD Cowen Starts Bright Minds Biosciences Inc. (DRUG) at Buy

May 7, 2025 04:30AM Chardan Capital Markets Starts Bright Minds Biosciences Inc. (DRUG) at Buy

Feb 20, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Bright Minds Biosciences Inc. (DRUG)

Jan 23, 2025 03:44AM Piper Sandler Starts Bright Minds Biosciences Inc. (DRUG) at Overweight

Jan 7, 2025 06:50AM Bright Minds Biosciences (DRUG) Appoints Stephen Collins as Chief Medical Officer

Nov 26, 2024 05:12AM Baird Starts Bright Minds Biosciences Inc. (DRUG) at Outperform

Nov 4, 2024 02:42PM Bright Minds Biosciences (DRUG) Closes US$35 Million Non-Brokered Private Placement

Oct 18, 2024 09:32AM Bright Minds Biosciences (DRUG) halted on volatility, up 82%

Oct 16, 2024 10:47AM Bright Minds Biosciences (DRUG) halted on volatility

Oct 16, 2024 10:46AM Bright Minds Biosciences (DRUG) proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models

Oct 16, 2024 09:21AM Firefly Neuroscience (AIFF) Collaborates with Bright Minds Biosciences (DRUG) to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA Technology

Oct 15, 2024 09:09PM Bright Minds is Unaware of Any Material Changes

Oct 15, 2024 04:36PM After-hours movers: United Airlines, Interactive Brokers, J.B. Hunt and more